Clinical Trial Update: Treatment Prioritisation and Cost-Effectiveness Analysis for HBV Cure - Real-World Evidence from a Territory-Wide Cohort

View source ↗

Summary

A ClinicalTrials.gov entry describing a real-world evidence study from a territory-wide cohort to prioritise HBV treatment and assess cost-effectiveness for an …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Snippet

Sponsor: Chinese University of Hong Kong | Conditions: Chronic Hepatitis B | Status: NOT_YET_RECRUITING